NovoCure Limited - Ordinary Shares (NQ:NVCR)

15.23 +0.29 (+1.94%)

Delayed Quote Updated: 12:37 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NovoCure Limited - Ordinary Shares

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

21 22 Next >

NASDAQ:NVCR Shareholder Notice: Lawsuit Alleges Securities Laws Violations by NovoCure Limited ↗

August 09, 2023

San Diego, CA -- (SBWIRE) -- 08/09/2023 -- The Shareholders Foundation announced that an investor, who purchased shares of NovoCure Limited (NASDAQ:NVCR), filed a lawsuit over alleged violations of...

Via SBWire

Topics Lawsuit

2 Incredibly Cheap Growth Stocks to Buy in August ↗

August 09, 2023

These two innovative growth stocks appear deeply undervalued based on their long-term potential.

Via The Motley Fool

Is NovoCure Stock a Buy Now? ↗

August 09, 2023

There's nobody else angling for its market share, but that might not be enough.

Via The Motley Fool

Why Novocure Was a Healthy Stock Today ↗

August 08, 2023

The company stands to win big if its cancer-fighting technology does well in a late-stage clinical trial.

Via The Motley Fool

Calling All NovoCure Limited (NVCR) Investors: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Class Action Lawsuit

August 08, 2023

New York, New York - Attorney Advertising–Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action

Via Law Firm Newswire

Topics Lawsuit

What 9 Analyst Ratings Have To Say About NovoCure ↗

August 04, 2023

Via Benzinga

NovoCure (NVCR) Q2 2023 Earnings Call Transcript ↗

July 27, 2023

NVCR earnings call for the period ending June 30, 2023.

Via The Motley Fool

NovoCure Earnings Preview ↗

July 26, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023 ↗

August 08, 2023

Via Benzinga

NVCR DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages NovoCure Limited Investors to Secure Counsel Before Important August 18 Deadline in Securities Class Action - NVCR

August 08, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

NOVOCURE LIMITED (NASDAQ: NVCR) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NovoCure Limited

August 08, 2023

From Bernstein Liebhard LLP

Via GlobeNewswire

NATIONALLY RANKED ROSEN LAW FIRM Encourages NovoCure Limited Investors to Secure Counsel Before Important August 18 Deadline in Securities Class Action - NVCR

August 07, 2023

WHY: New York, NY - (NewMediaWire) - August 07, 2023 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of NovoCure Limited (NASDAQ: NVCR) between January 5, 2023 and...

Via NewMediaWire

Topics Lawsuit

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Futu, DZS, TriplePoint, and NovoCure and Encourages Investors to Contact the Firm

August 06, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

FINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $250,000 to Contact the Firm

August 06, 2023

Via ACCESSWIRE

ROSEN, SKILLED INVESTOR COUNSEL, Encourages NovoCure Limited Investors with Losses to Secure Counsel Before Important August 18 Deadline in Securities Class Action - NVCR

August 04, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2023 ↗

August 04, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

August 01, 2023

On Tuesday, 46 stocks hit new 52-week lows.

Via Benzinga

Calling All NovoCure Limited (NVCR) Investors: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Class Action Lawsuit

August 01, 2023

New York, New York - Attorney Advertising – Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action

Via Law Firm Newswire

Topics Lawsuit

NVDR DEADLINE REMINDER: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NovoCure Limited

August 01, 2023

From Bernstein Liebhard LLP

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Futu, DZS, TriplePoint, and NovoCure and Encourages Investors to Contact the Firm

July 31, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages NovoCure Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action – NVCR

July 31, 2023

From The Rosen Law Firm PA

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023 ↗

July 31, 2023

Via Benzinga

TOP RANKED ROSEN LAW FIRM Encourages NovoCure Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVCR

July 29, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Stocks That Hit 52-Week Lows On Friday ↗

July 28, 2023

Friday's session saw 59 companies set new 52-week lows.

Via Benzinga

Lost Money in NovoCure Limited? Gibbs Law Group Investigates Potential Securities Law Violations

July 27, 2023

From Gibbs Law Group

Via Business Wire

Why Novocure Stock Tumbled by Nearly 16% Today ↗

July 27, 2023

The company posted a notably deeper net loss in its freshly reported quarter, while its revenue fell.

Via The Motley Fool

Stocks That Hit 52-Week Lows On Thursday ↗

July 27, 2023

During Thursday, 56 stocks hit new 52-week lows.

Via Benzinga

Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

July 27, 2023

Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control.

Via Benzinga

Novocure Reports Second Quarter 2023 Financial Results

July 27, 2023

From Novocure

Via Business Wire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Futu, DZS, TriplePoint, and NovoCure and Encourages Investors to Contact the Firm

July 26, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.